Gastric and Esophageal Cancer Drugs Market - Industry Growth, and Analysis 2018-2026embed
Increasing number of cancer drugs in pipeline studies and rising involvement of key players for development of cancer treatment are expected to propel gastric and esophageal cancer drugs market growth.
Gastric and Esophageal Cancer Drugs Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026 REPORT DESCRIPTION Gastric and Esophageal Cancer Drugs Market – Overview Increasing number of cancer drugs in pipeline studies and rising involvement of key players for development of cancer treatment are expected to propel gastric and esophageal cancer drugs market growth. For instance, in April 2016, Centre Hospitalier Universitaire de Besancon, initiated Phase 1 and Phase 2 clinical trial for Carboplatin to determine the maximum tolerated dose (MTD) and recommended doses for phase II (RP2D) by considering the treatment scheme of Dutch study for chemotherapy and radiotherapy. The study is conducted in elderly patients with esophagus cancer. Carboplatin is an anticancer chemotherapy drug from alkylating agent category. The study is estimated to complete by April 2024. Moreover, in February 2017, Henan Cancer Hospital in collaboration with Jiangsu HengRui Medicine Co., Ltd., initiated Phase 2 exploratory clinical trial to evaluate the efficacy of Apatinib, treatment for advanced esophagus cancer. Apatinib is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2(VEGFR2). However, high cost of therapy for the treatment of gastric and esophageal cancers is expected to restraint the market growth. For instance, as per the report published in Healthday, in 2013, cancer patients paid US$ 207,000 a year for the treatment and medications while in 1995 the cost was US$ 54,100 a year. REPORT DESCRIPTION Gastric and Esophageal Cancer Drugs Market Taxonomy: By Therapy Type Chemotherapy Targeted Therapy Immunotherapy By Disease Indication Adenocarcinomas Gastrointestinal Stromal Tumors Carcinoid Tumors Squamous Cell Carcinoma Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2438 REPORT DESCRIPTION Gastric and Esophageal Cancer Drugs Market – Key Players Amgen Eli Lilly and Company F. Hoffmann-La Roche Bristol-Myers Squibb Company Boehringer Ingelheim GmbH Bristol-Myers Squibb GlaxoSmithKline Plc Novartis AG Johnson & Johnson Gilead Sciences Merck & Co Get More Inf @ https://www.coherentmarketinsights.com/ongoing-insight/gastric-and-esophageal-cancer-drugs-market-2438 ABOUT COHERENT MARKET INSIGHTS Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES CUSTOMIZED RESEARCH CONSULT STUDIES SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies ABOUT US KEY STATS RESEARCH SOLUTIONS FEASIBILITY STUDIES GLOBAL REPORTS 100+ Insights Published Per Year 150+ Consulting Projects Till Date 125+ Clients Worldwide Per Year 110+ COUNTRY ANALYSIS CONSULT PROJECTS SURVEY RESEARCH EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique —we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: [email protected] For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights [email protected] +1-206-701-6702